Patent details

300578 Product Name: Teduglutide.

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
300578
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP0906338
Status:
Expired Art. 14 (a) of the EC Regulations
Application number:
300578
Procedural language:
Dutch
First Applicant Residence Country:

Marketing Authorization

Marketing Authorization Number:
EU/1/12/787/001
Marketing Authorization Type:
EEA
Marketing Authorization Date:
30/08/2012
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
27/02/2013
First Marketing Authorization date:
30/08/2012
Grant date:
06/08/2013
Activation date:
11/04/2017
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
27/02/2013
SPC/SPC Extension Expiration Date:
10/04/2022
Lapsed By Expiration Date:
11/04/2022
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
03/05/2017
 
 

 

Name:
SHIRE-NPS PHARMACEUTICALS, INC.
Address:
300 Shire Way, 02421, Lexington, MA, United States of America (US)

From:
03/05/2017
 
 

 

Name:
1149336 ONTARIO INC.
Address:
19 Fernwood Road, M6B 3G3, Toronto, Ontario, Canada (CA)

Historical Applicant/holder

From:
27/02/2013
To:
03/05/2017

 

Name:
1149336 ONTARIO INC.
Address:
19 Fernwood Road, M6B 3G3, Toronto, Ontario, Canada (CA)

From:
27/02/2013
To:
03/05/2017

 

Name:
NPS Pharmaceuticals, Inc.
Address:
550 Hills Drive, Third Floor, 07921, Bedminster, New Jersey, United States of America (US)

Agent

Name:
ir. A. Blokland c.s.
From:
27/02/2013
Address:
Algemeen Octrooi- en Merkenbureau B.V. Postbus 645, 5600 AP, Eindhoven, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
15/22
Publication date:
13/04/2022
Description:
Lapse or annulment

2

Bulletin Heading:
CO
Journal edition number:
30/17
Publication date:
26/07/2017
Description:
Changes in the Netherlands Patent Register

3

Bulletin Heading:
SPC
Journal edition number:
15/17
Publication date:
19/04/2017
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

4

Bulletin Heading:
SPC
Journal edition number:
2013/33
Publication date:
14/08/2013
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

5

Bulletin Heading:
SPC
Journal edition number:
2013/11
Publication date:
13/03/2013
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name
Deed Number:
RC201701034B
Date Registered:
03/05/2017
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

1

Name:
1149336 ONTARIO INC.
Address:
19 Fernwood Road, M6B 3G3, Toronto, Ontario, Canada (CA)

2

Name:
SHIRE-NPS PHARMACEUTICALS, INC.
Address:
300 Shire Way, 02421, Lexington, MA, United States of America (US)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
29/03/2021
Last Annual Fee Paid Number:
25
Last Annual Fee Paid Amount:
2400 Euro
Payer:
Anaqua Services
Filing date Document type Document Description Number of pages File Type
06/08/2013 Outgoing Correspondence Outgoing Letter 1 PDF /8/7/5/0/0/0400300578/docs/300578_3_outgoingcorrespondence20130806.pdf
06/08/2013 SPC Documents Certificate SPC 1 PDF /8/7/5/0/0/0400300578/docs/300578_9_supplprotectioncertificate20210301042822962.pdf
05/06/2013 Incoming Correspondence Paper Accompanying letter incoming document 1 PDF /8/7/5/0/0/0400300578/docs/300578_4_incomingcorrespondencepaper20130605.pdf
26/03/2013 Outgoing Correspondence Outgoing Letter 2 PDF /8/7/5/0/0/0400300578/docs/300578_0_outgoingcorrespondence20130326.pdf
05/03/2013 Outgoing Correspondence Outgoing Letter 1 PDF /8/7/5/0/0/0400300578/docs/300578_11_outgoingcorrespondence20130305.pdf
27/02/2013 SPC Documents Summary of the characteristics of the product 13 PDF /8/7/5/0/0/0400300578/docs/300578_1_supplprotectioncertificate20210301042134752.pdf
27/02/2013 Application Form First filed application form 4 PDF /8/7/5/0/0/0400300578/docs/300578_2_applicationform20130227.pdf
27/02/2013 SPC Documents Annex SPC 3 PDF /8/7/5/0/0/0400300578/docs/300578_5_supplprotectioncertificate20210301042134826.pdf
27/02/2013 SPC Documents Accompanying letter SPC 3 PDF /8/7/5/0/0/0400300578/docs/300578_6_supplprotectioncertificate20210301040644147.pdf
27/02/2013 SPC Documents Annex SPC 17 PDF /8/7/5/0/0/0400300578/docs/300578_7_supplprotectioncertificate20210301042134907.pdf
27/02/2013 SPC Documents Annex SPC 1 PDF /8/7/5/0/0/0400300578/docs/300578_8_supplprotectioncertificate20210301040503743.pdf
27/02/2013 SPC Documents Marketing Authorization SPC 4 PDF /8/7/5/0/0/0400300578/docs/300578_10_supplprotectioncertificate20210301041631919.pdf